Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Greth Lyndal FANG Diamondback Energy, Inc. 13D 38.9% 2y
FIFTHDELTA Ltd INVZ Innoviz Technologies Ltd. 13G/A 0.48% 2y
NEEDHAM INVESTMENT MANAGEMENT LLC MTRX Matrix Service Co 13G 4.99% 2y
Amberjack Capital Partners, L.P. INVX Innovex International, Inc. 13D 44.1% 2y
ATW Growth Opportunities SPV, LLC WKHS Workhorse Group Inc. 13G 9.9% 2y
Darsana Capital Partners LP SHC Sotera Health Co 13G 7.1% 2y
Dr. Avi S. Katz QTI Qt Imaging Holdings, Inc. 13D/A 1% 2y
Kent Lake PR LLC HHS Harte Hanks Inc 13G 5% 2y
Durable Capital Partners LP CIGI Colliers International Group Inc. 13G 5.2% 2y
Redmile Group, LLC ATRA Atara Biotherapeutics, Inc. 13G/A 9.9% 2y
BARD ASSOCIATES INC AMPG AmpliTech Group, Inc. 13G 18.6% 2y
Tadano Ltd. MNTX Manitex International, Inc. 13D/A 14.5% 2y
Private Capital Management, LLC MPAA Motorcar Parts Of America Inc 13G 1.27% 2y
Saba Capital Management, L.P. PEO Adams Natural Resources Fund, Inc. 13D/A 11.28% 2y
KUMARAKULASINGAM SURIYAKUMAR ARC ARC Document Solutions, Inc. 13D/A 19.6% 2y
Michael A. Davis (“Davis”) CYAN Cyanotech Corp 13D/A 23.8% 2y
Cerberus Capital Management II, L.P. EOSE Eos Energy Enterprises, Inc. 13D/A 32.4% 2y
Caligan Partners LP LQDA Liquidia Corp 13D/A 9.6% 2y
Karpus Management, Inc. NEA Nuveen AMT-Free Quality Municipal Income Fund 13D/A 6.25% 2y
Grupo Angeles Servicios de Salud, S.A. de C.V. AUNA Auna S.A. 13D/A 22.2% 2y
Opaleye Management Inc. ETON Eton Pharmaceuticals, Inc. 13G/A 10.34% 2y
Millennium Management LLC ALGS Aligos Therapeutics, Inc. 13G 4.1% 2y
Y.D. More Investments Ltd TATT Tat Technologies Ltd 13G 12.4% 2y
TANG CAPITAL MANAGEMENT LLC AUPH Aurinia Pharmaceuticals Inc. 13D 5.1% 2y
Deerfield Management Company, L.P. OMIC Singular Genomics Systems, Inc. Common Stock 13D 6.66% 2y
Mitchell P. Kopin VJET Flyte Aviation, Inc. 13G 9.5% 2y
Nabil Saad BFRI Biofrontera Inc. 13G 6.09% 2y
Jiang Liu SONM DNA X, Inc. 13G 9.9% 2y
Viridian, LLC DNTH Dianthus Therapeutics, Inc. 13D/A 3.72% 2y
Todd Deutsch AIM AIM ImmunoTech Inc. 13D/A 3% 2y
Yoda PLC CCEC Capital Clean Energy Carriers Corp. 13D/A 25.2% 2y
Cloud Alliance Inc QH QUHUO Ltd 13D/A 0% 2y
Tether Holdings Limited AGRO Adecoagro S.A. 13D/A 11.6% 2y
Hess Investments North Dakota LLC HESM Hess Midstream LP 13D/A 47.8% 2y
GENERAL ATLANTIC, L.P. SQSP Squarespace, Inc. 13D/A 16.3% 2y
Axonic Capital LLC PW Power REIT 13D/A 5.4% 2y
John C. Malone SIRI Sirius Xm Holdings Inc. 13D 6.5% 2y
Dan Hagan LUMN Lumen Technologies, Inc. 13G 5.4% 2y
Lux Donn S. CASK Sempreon, Inc 13D/A 35% 2y
SPRUCE HOUSE INVESTMENT MANAGEMENT LLC CMPR CIMPRESS plc 13D/A 8.28% 2y
GIP II Blue Holding, L.P. HESM Hess Midstream LP 13D/A 33.4% 2y
Anthony Casalena SQSP Squarespace, Inc. 13D/A 33.5% 2y
Margolin Marc Leslie ADMT Adm Tronics Unlimited, Inc. 13G 5.4% 2y
Funicular Funds, LP CLDI Calidi Biotherapeutics, Inc. 13G 9.99% 2y
ALLIANCEBERNSTEIN L.P. NATL NCR Atleos Corp 13G 10.2% 2y
Christopher Todd SPAI Safe Pro Group Inc. 13D 5.3% 2y
Daniyel Erdberg SPAI Safe Pro Group Inc. 13D 39% 2y
Pravin Borkar SPAI Safe Pro Group Inc. 13D 11% 2y
GEM Global Yield LLC SCS SRFM Surf Air Mobility Inc. 13G 9.9% 2y
West Lake Club Inc. INHD Inno Holdings Inc. 13D 30.84% 2y